Palbociclib Hydrochloride
Palbociclib Hydrochloride, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. Reference standards of Palbociclib Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.


Palbociclib Hydrochloride
Catalogue No.:PA 16 3010000
CAS :
827022-32-2
Molecular Formula : C24H30ClN7O2
Molecular Weight : 484